At the Rosenberg School of Optometry at the University of the Incarnate Word, fourth-years get hands-on experience in care for patients pre- and post-surgery, preparing them for real-world comanaging relationships.
Study groups can help their members via group discussion and sharing. If you’re looking to form or join a study group, find out what leads to success.
Genetic testing is becoming more successful and is expanding in scope. Understand how the process works and how to guide your patients through it. Find out what is involved and how to manage genetic testing…plus access a list of resources for you and your patient.
A comanaging MD discusses what five traits should be part of any OD-MD comanaging relationship. Setting patient expectations on both ends is the underlying framework.
What is this age-defying modern technology that a young, nonmedical professional is applying to her face? It is a YAG laser combined with an intense pulse light (IPL).
As primary-care optometrists, we are the gatekeepers for baby boomers inquiring about cataract surgery. Today’s patients have treatment options available not only to address their lifestyle complaints but to provide them with better vision and possibly reduced dependence on glasses or contact lenses.
Patients don’t have to wait for 2020 to achieve 20/20 vision at near without spectacles or contact lenses. Rather, the advancements we have seen just in the past few years should be enough to help manage their expectations.
Before the new year gets too far along, let’s take a brief look at the happenings in the pages of Optometry Times during 2016.
I am again reminding you that optometry has a renewed purpose in the management of our cataract and refractive patients.
A U.S. patent was granted to Gholam A. Peyman, MD, in June 1989 for a method of modifying the corneal curvature of the eye. The surgical procedure involved cutting a flap in the cornea, pulling the flap back to expose the corneal bed, ablating the exposed surface and then replacing the flap. The current procedure of laser assisted in-situ keratomileusis (LASIK) was not FDA approved until 1999.